347 related articles for article (PubMed ID: 15881895)
1. The epigenetic breakdown of cancer cells: from DNA methylation to histone modifications.
Ballestar E; Esteller M
Prog Mol Subcell Biol; 2005; 38():169-81. PubMed ID: 15881895
[TBL] [Abstract][Full Text] [Related]
2. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
Kn H; Bassal S; Tikellis C; El-Osta A
Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
[TBL] [Abstract][Full Text] [Related]
3. Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins.
Tryndyak VP; Kovalchuk O; Pogribny IP
Cancer Biol Ther; 2006 Jan; 5(1):65-70. PubMed ID: 16322686
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic aberrations during oncogenesis.
Hatziapostolou M; Iliopoulos D
Cell Mol Life Sci; 2011 May; 68(10):1681-702. PubMed ID: 21249513
[TBL] [Abstract][Full Text] [Related]
5. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
Valdespino-Gómez VM; Valdespino-Castillo VE
Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
[TBL] [Abstract][Full Text] [Related]
6. Targeting epigenetic regulations in cancer.
Ning B; Li W; Zhao W; Wang R
Acta Biochim Biophys Sin (Shanghai); 2016 Jan; 48(1):97-109. PubMed ID: 26508480
[TBL] [Abstract][Full Text] [Related]
7. Reversing aberrant methylation patterns in cancer.
Poke FS; Qadi A; Holloway AF
Curr Med Chem; 2010; 17(13):1246-54. PubMed ID: 20166939
[TBL] [Abstract][Full Text] [Related]
8. Interactions between core histone marks and DNA methyltransferases predict DNA methylation patterns observed in human cells and tissues.
Fu K; Bonora G; Pellegrini M
Epigenetics; 2020 Mar; 15(3):272-282. PubMed ID: 31509087
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation as a target of epigenetic therapeutics in cancer.
Li KK; Li F; Li QS; Yang K; Jin B
Anticancer Agents Med Chem; 2013 Feb; 13(2):242-7. PubMed ID: 22934696
[TBL] [Abstract][Full Text] [Related]
10. Towards the human cancer epigenome: a first draft of histone modifications.
Fraga MF; Esteller M
Cell Cycle; 2005 Oct; 4(10):1377-81. PubMed ID: 16205112
[TBL] [Abstract][Full Text] [Related]
11. Aberrant promoter methylation of the ABCG2 gene in renal carcinoma.
To KK; Zhan Z; Bates SE
Mol Cell Biol; 2006 Nov; 26(22):8572-85. PubMed ID: 16954373
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation and cancer therapy.
Szyf M
Drug Resist Updat; 2003 Dec; 6(6):341-53. PubMed ID: 14744498
[TBL] [Abstract][Full Text] [Related]
13. [DNA methylation and cancer].
Yoshikawa H
Gan To Kagaku Ryoho; 2007 Feb; 34(2):145-9. PubMed ID: 17301518
[TBL] [Abstract][Full Text] [Related]
14. Intragenic DNA methylation prevents spurious transcription initiation.
Neri F; Rapelli S; Krepelova A; Incarnato D; Parlato C; Basile G; Maldotti M; Anselmi F; Oliviero S
Nature; 2017 Mar; 543(7643):72-77. PubMed ID: 28225755
[TBL] [Abstract][Full Text] [Related]
15. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene.
Bachman KE; Park BH; Rhee I; Rajagopalan H; Herman JG; Baylin SB; Kinzler KW; Vogelstein B
Cancer Cell; 2003 Jan; 3(1):89-95. PubMed ID: 12559178
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional repressive H3K9 and H3K27 methylations contribute to DNMT1-mediated DNA methylation recovery.
Wong CM; Wong CC; Ng YL; Au SL; Ko FC; Ng IO
PLoS One; 2011 Feb; 6(2):e16702. PubMed ID: 21347439
[TBL] [Abstract][Full Text] [Related]
17. Aberrant DNA hypermethylation patterns lead to transcriptional silencing of tumor suppressor genes in UVB-exposed skin and UVB-induced skin tumors of mice.
Nandakumar V; Vaid M; Tollefsbol TO; Katiyar SK
Carcinogenesis; 2011 Apr; 32(4):597-604. PubMed ID: 21186298
[TBL] [Abstract][Full Text] [Related]
18. The role of epigenetic transcription repression and DNA methyltransferases in cancer.
Daniel FI; Cherubini K; Yurgel LS; de Figueiredo MA; Salum FG
Cancer; 2011 Feb; 117(4):677-87. PubMed ID: 20945317
[TBL] [Abstract][Full Text] [Related]
19. DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge.
Castillo-Aguilera O; Depreux P; Halby L; Arimondo PB; Goossens L
Biomolecules; 2017 Jan; 7(1):. PubMed ID: 28067760
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic cross-talk between DNA methylation and histone modifications in human cancers.
Kondo Y
Yonsei Med J; 2009 Aug; 50(4):455-63. PubMed ID: 19718392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
